drugset / Trial / NCT03739476

Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients

NCT03739476

RandomizedParallel-groupDouble-blindTreatment

Summary

Double blinded Clinical trial to test efficacy of Quetiapine versus placebo in reducing postoperative delirium in high risk surgical patients after three days of treatment.

Timeline

Start
2019-02-13
Primary completion
2020-04-02
Completion
2020-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 25 mg

Indications